1. Home
  2. ONVO vs SISI Comparison

ONVO vs SISI Comparison

Compare ONVO & SISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONVO
  • SISI
  • Stock Information
  • Founded
  • ONVO 2007
  • SISI 1997
  • Country
  • ONVO United States
  • SISI China
  • Employees
  • ONVO N/A
  • SISI N/A
  • Industry
  • ONVO Biotechnology: Biological Products (No Diagnostic Substances)
  • SISI Medicinal Chemicals and Botanical Products
  • Sector
  • ONVO Health Care
  • SISI Health Care
  • Exchange
  • ONVO Nasdaq
  • SISI Nasdaq
  • Market Cap
  • ONVO 6.5M
  • SISI 5.9M
  • IPO Year
  • ONVO N/A
  • SISI 2016
  • Fundamental
  • Price
  • ONVO $0.39
  • SISI $1.69
  • Analyst Decision
  • ONVO
  • SISI
  • Analyst Count
  • ONVO 0
  • SISI 0
  • Target Price
  • ONVO N/A
  • SISI N/A
  • AVG Volume (30 Days)
  • ONVO 243.5K
  • SISI 617.5K
  • Earning Date
  • ONVO 02-06-2025
  • SISI 02-06-2025
  • Dividend Yield
  • ONVO N/A
  • SISI N/A
  • EPS Growth
  • ONVO N/A
  • SISI N/A
  • EPS
  • ONVO N/A
  • SISI N/A
  • Revenue
  • ONVO $103,000.00
  • SISI $10,330,284.00
  • Revenue This Year
  • ONVO $59.08
  • SISI N/A
  • Revenue Next Year
  • ONVO $18.24
  • SISI N/A
  • P/E Ratio
  • ONVO N/A
  • SISI N/A
  • Revenue Growth
  • ONVO N/A
  • SISI 370.34
  • 52 Week Low
  • ONVO $0.32
  • SISI $1.63
  • 52 Week High
  • ONVO $1.74
  • SISI $117.65
  • Technical
  • Relative Strength Index (RSI)
  • ONVO 47.81
  • SISI 40.61
  • Support Level
  • ONVO $0.34
  • SISI $1.63
  • Resistance Level
  • ONVO $0.51
  • SISI $1.89
  • Average True Range (ATR)
  • ONVO 0.06
  • SISI 0.67
  • MACD
  • ONVO -0.00
  • SISI -0.06
  • Stochastic Oscillator
  • ONVO 30.00
  • SISI 1.58

About ONVO Organovo Holdings Inc.

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

About SISI Shineco Inc.

Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.

Share on Social Networks: